Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Burden, Health Disparities, and Projections of Lower Extremity Peripheral Artery Disease: Insights from Global Burden of Disease, Injuries, and Risk Factors Study 2021.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2025
Same author

Glutamine: fructose-6-phosphate amidotransferase (GFAT) in the pathology of diseases: a review.

Cell death discovery·2025
Same author

LPATR-Net: Learnable Piecewise Affine Transformation Regression Assisted Data-Driven Dehazing Framework.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2025
Same author

Synergistic and heterogeneous aging using composite phenotypes and multiple organ systems aging clocks.

Communications medicine·2025
Same author

Single-cell RNA sequencing reveals immune cell dysfunction and rewired interaction networks in the peripheral blood of active tuberculosis patients.

BMC immunology·2025
Same author

Integrating Bibliometrics and Bioinformatics to Map Knowledge Structure and Trend Synthesis in Rheumatoid Arthritis and Bone Erosion (2015-2024).

Journal of multidisciplinary healthcare·2025

Related Experiment Video

Updated: May 24, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Predicting analysis time in event-driven clinical trials with event-reporting lag.

Jianming Wang1, Chunlei Ke, Qi Jiang

  • 1Oncology Biometrics and Data Management, Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA. jianming.wang@novartis.com

Statistics in Medicine
|February 21, 2012
PubMed
Summary

Accurate clinical trial analysis time prediction is crucial. This study introduces a parametric model to account for event-reporting lag, improving prediction accuracy for time-to-event endpoints.

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Related Experiment Videos

Last Updated: May 24, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Area of Science:

  • Clinical trial methodology
  • Biostatistics
  • Health research analysis

Background:

  • Predicting clinical trial analysis timing is critical for resource allocation and strategic planning.
  • Current prediction models often assume complete data reporting, neglecting event-reporting lag.
  • Event-reporting lag can lead to incomplete data, potentially impacting prediction accuracy.

Purpose of the Study:

  • To develop a general parametric model for predicting clinical trial analysis time.
  • To incorporate the impact of event-reporting lag into analysis time predictions.
  • To enhance the accuracy of early predictions for time-to-event clinical trials.

Main Methods:

  • A general parametric model was developed to integrate event-reporting lag.
  • A Bayesian prediction procedure was formulated.
  • The method was implemented using exponential distributions and evaluated through simulations.

Main Results:

  • The proposed parametric model effectively incorporates event-reporting lag.
  • Simulations demonstrated the performance of the Bayesian prediction procedure.
  • The method was applied to an ongoing clinical trial, showing practical utility.

Conclusions:

  • Accounting for event-reporting lag is essential for accurate clinical trial analysis time prediction.
  • The developed parametric and Bayesian approach provides a robust method for prediction.
  • This methodology can improve strategic planning and resource management in clinical trials.